secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCardia, Inc. (BCDA)
CIK:        0000925741
Form:       8-K
Filed at:   2025-07-02T23:59:59+00:00
Accession:  0001437749-25-021906
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCardia raises ~$570K in private placement of stock and warrants
------------------------------------------------------------------

- Sold 274,696 shares and warrants at $2.075/unit, gross proceeds ~$570,000.
- Warrants exercisable at $1.95/share until 6/30/2030 or PMDA approval of CardiAMP.
- Directors/officers invested $360K, including CEO Peter Altman ($50K) and CFO David McClung ($10K).
- Proceeds for general corporate purposes; registration statement to be filed by July 10, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/925741/000143774925021906/0001437749-25-021906-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/925741/000143774925021906/bcda20250701_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-021906

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer